Literature DB >> 24980966

Experiences and unmet needs of women undergoing Pap smear cervical cancer screening: impact on uptake of cervical cancer screening in south eastern Nigeria.

Chibuike O Chigbu1, Azubuike K Onyebuchi, Chuma C Egbuji, Eusebus C Ezugwu.   

Abstract

The burden of cervical cancer is on the increase in sub-Saharan Africa mainly due to inadequate provision and utilisation of cervical cancer prevention services. Several evidence-based strategies have been deployed to improve cervical cancer screening uptake without much success. However, patients' experiences and satisfaction with service provision has not been adequately studied. Inefficiencies in service delivery and less fulfilling experiences by women who attend cervical cancer screening could have considerable impact in future voluntary uptake of cervical cancer screening. Six hundred and eighty women who underwent Pap smear screening in three health care facilities in two states in south eastern Nigeria were interviewed to evaluate their satisfaction, willingness to undertake future voluntary screening, unmet needs and correlation between satisfaction level and willingness to undergo future screening. Satisfaction with Pap smear screening correlated positively with willingness to undertake future voluntary screening (Pearson's correlation coefficient = 0.78, P = 0.001). The mean satisfaction score was significantly higher among participants handled by nurses than those handled by the physicians (3.16 ± 0.94 vs 2.52 ± 0.77, P = 0.001). 'Scrapping discomfort' of the spatula was reported as the most dissatisfying aspect of Pap smear experience. The need for less invasive screening procedures was the most unmet need. It was concluded that improving the Pap smear screening experience of women and providing less invasive methods of cervical cancer screening with immediate results could improve uptake of cervical cancer screening in south eastern Nigeria.

Entities:  

Mesh:

Year:  2015        PMID: 24980966     DOI: 10.1007/s13187-014-0691-1

Source DB:  PubMed          Journal:  J Cancer Educ        ISSN: 0885-8195            Impact factor:   2.037


  14 in total

1.  Improved awareness of Pap smear may not affect its use in Nigeria: a case study of female medical practitioners in Enugu, southeastern Nigeria.

Authors:  Cyril C Dim; Esther Ekwe; Theresa Madubuko; Ngozi R Dim; Hyginus U Ezegwui
Journal:  Trans R Soc Trop Med Hyg       Date:  2009-04-23       Impact factor: 2.184

2.  Human papillomavirus is a necessary cause of invasive cervical cancer worldwide.

Authors:  J M Walboomers; M V Jacobs; M M Manos; F X Bosch; J A Kummer; K V Shah; P J Snijders; J Peto; C J Meijer; N Muñoz
Journal:  J Pathol       Date:  1999-09       Impact factor: 7.996

3.  Why southeastern Nigerian women who are aware of cervical cancer screening do not go for cervical cancer screening.

Authors:  Chibuike Ogwuegbu Chigbu; Uzochukwu Aniebue
Journal:  Int J Gynecol Cancer       Date:  2011-10       Impact factor: 3.437

Review 4.  Cervical cancer in Africa.

Authors:  Lynette Denny; Rose Anorlu
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2012-07-17       Impact factor: 4.254

5.  Motivations and preferences of rural Nigerian women undergoing cervical cancer screening via visual inspection with acetic acid.

Authors:  Chibuike O Chigbu; Azubuike K Onyebuchi; Leonard O Ajah; Elijah N Onwudiwe
Journal:  Int J Gynaecol Obstet       Date:  2012-12-08       Impact factor: 3.561

6.  Women's experience of coping with a positive Pap smear: A register-based study of women with two consecutive Pap smears reported as CIN 1.

Authors:  Monica Ideström; Ian Milsom; Agneta Andersson-Ellström
Journal:  Acta Obstet Gynecol Scand       Date:  2003-08       Impact factor: 3.636

7.  Participation in highly subsidized cervical cancer screening by women in Enugu, South-east Nigeria.

Authors:  S N Obi; B C Ozumba; A R Nwokocha; P A Waboso
Journal:  J Obstet Gynaecol       Date:  2007-04       Impact factor: 1.246

8.  The need to incorporate routine cervical cancer counselling and screening in the management of women at the outpatient clinics in Nigeria.

Authors:  C C Dim; U I Nwagha; H U Ezegwui; N R Dim
Journal:  J Obstet Gynaecol       Date:  2009-11       Impact factor: 1.246

Review 9.  Cervical cancer: the sub-Saharan African perspective.

Authors:  Rose I Anorlu
Journal:  Reprod Health Matters       Date:  2008-11

10.  Women's experience of colposcopy: a qualitative investigation.

Authors:  Dawn R Swancutt; Sheila M Greenfield; David M Luesley; Sue Wilson
Journal:  BMC Womens Health       Date:  2011-04-13       Impact factor: 2.809

View more
  4 in total

1.  Setting up a community-based cervical screening service in a low-income country: a pilot study from north-western Tanzania.

Authors:  Nestory Masalu; Patrizia Serra; Dino Amadori; Jackson Kahima; Charles Majinge; Joyce Rwehabura; Oriana Nanni; Sara Bravaccini; Maurizio Puccetti; Rosario Tumino; Lauro Bucchi
Journal:  Int J Public Health       Date:  2017-04-19       Impact factor: 3.380

2.  Association of Sociodemographic Factors, Breast Cancer Fear, and Perceived Self-Efficacy With Breast Cancer Screening Behaviors Among Middle-Aged Nigerian Women.

Authors:  Rita Ngozi Ezema; Charles Chima Igbokwe; Tochi Emmanuel Iwuagwu; Olaoluwa Samson Agbaje; Justina Ifeoma Ofuebe; Lawretta Ijeoma Abugu; Dorothy Doris Eze; Yohanna Wamanyi
Journal:  Breast Cancer (Auckl)       Date:  2021-09-30

3.  Experiences of women awaiting cervical CANCER screening results from selected hospitals in Accra, Ghana.

Authors:  Evans Appiah Osei; Stella Appiah; Ezekiel Oti-Boadi; Dorothy Hammond; Dorothy Baffour Awuah; Awube Menlah; Isabella Garti; Michael Baidoo
Journal:  BMC Public Health       Date:  2022-08-01       Impact factor: 4.135

Review 4.  Cervical Cancer and Human Papillomavirus Vaccine Knowledge, Utilisation, Prevention Educational Interventions and Policy Response in Nigeria: A Scoping Review.

Authors:  Yetunde O John-Akinola; Chizoma M Ndikom; Mojisola M Oluwasanu; Temitayo Adebisi; Oluwaponmile Odukoya
Journal:  Cancer Control       Date:  2022 Jan-Dec       Impact factor: 2.339

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.